RTW Investments, LP 13D/13G Filings for Mirati Therapeutics, Inc. (MRTX)

RTW Investments, LP 13D and 13G filings for Mirati Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
07:12 am
Sale
2023-12-31 13G Mirati Therapeutics, Inc.
MRTX
RTW Investments, LP 0
0.000%
-3,643,114decrease
(Position Closed)
Filing
2023-02-14
10:09 am
Purchase
2022-12-31 13G Mirati Therapeutics, Inc.
MRTX
RTW Investments, LP 3,643,114
6.300%
3,643,114increase
(New Position)
Filing